Johnson & Johnson
NYSE: JNJ
$142.06
-$0.21 (-0.1%)
Closing Price on January 10, 2025
JNJ Articles
The Reputation Institution has released its list of top 100 most reputable companies based on U.S. consumer perceptions.
Published:
Last Updated:
For the S&P 500 index to move toward a new record, the prices of some of the largest components will need to make most of the momentum.
Published:
Last Updated:
For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made a couple additions and updated its price target information.
Published:
Last Updated:
Monday's top analyst upgrades, downgrades and initiations Include Equinix, HCA, Johnson & Johnson, Performance Sports, Tesla and Yandex.
Published:
Last Updated:
With investors looking for safety and dividends for total return, the big pharmaceutical stocks are just the ticket, and these four are outstanding.
Published:
Last Updated:
It is time to take a look at the 2016 stock buyback kings, those companies that will spend the most buying back their common stock this year alone.
Published:
Last Updated:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. February 5, 2016: Markets opened lower on Friday...
Published:
Last Updated:
Johnson & Johnson reported its fourth-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
Johnson & Johnson is set to release its fourth-quarter financial results before the markets open Tuesday.
Published:
Last Updated:
24/7 Wall St. has put together a preview of some of the Dow Jones Industrial Average companies (and others) that are reporting their quarterly results this week.
Published:
Last Updated:
Investors need to keep in mind that the downside target for the Dow Jones Industrial Average will sink lower if the market keeps drifting south.
Published:
Last Updated:
Johnson & Johnson is looking to save some money over the next few years and as a result it is taking action by restructuring its Medical Devices businesses.
Published:
Last Updated:
24/7 Wall Street has evaluated three major Dow components in the pharmaceutical industry and presented the bullish and bearish case for each in 2016.
Published:
Last Updated:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. ThinkstockIn the second quarter of this year, U.S....
Published:
Last Updated:
ThinkstockJanssen Biotech announced that the U.S. Food and Drug Administration (FDA) approved Yondelis (trabectedin) for the treatment of patients with unresectable or metastatic liposarcoma (LPS) or...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.